Perspective Therapeutics CATX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's financing cash flow?
- Perspective Therapeutics (CATX) reported financing cash flow of $164.36M in Q1 2026.
- How has Perspective Therapeutics's financing cash flow changed year-over-year?
- Perspective Therapeutics's financing cash flow increased by 1548.1% year-over-year, from $9.97M to $164.36M.
- What is the long-term trend for Perspective Therapeutics's financing cash flow?
- Over 3 years (2022 to 2025), Perspective Therapeutics's financing cash flow has grown at a 469.0% compound annual growth rate (CAGR), from $56K to $10.32M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.